CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.
about
Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injuryHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesIs lipid signaling through cannabinoid 2 receptors part of a protective system?Vascular targets for cannabinoids: animal and human studiesTriphasic blood pressure responses to cannabinoids: do we understand the mechanism?The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcriptionEffects of total flavonoids from Dracocephalum moldavica on the proliferation, migration, and adhesion molecule expression of rat vascular smooth muscle cells induced by TNF-αRegulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cellsCannabinoids as novel anti-inflammatory drugs.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null miceThe role of endocannabinoids in pain modulation.Isolation and characterization of two plasmids in a clinical Acinetobacter nosocomialis strain.CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsCannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationCannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseasesEndogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation.Modulating the endocannabinoid system in human health and disease--successes and failuresModulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitationsNeuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activationExpression of the endocannabinoid receptors in human fascial tissueCannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferationCannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease.The role of the endocannabinoid system in atherosclerosis.CB1 cannabinoid receptor inhibition: promising approach for heart failure?Cannabinoid receptor CB2 protects against balloon-induced neointima formation.Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.Antimicrobial activity of novel nanostructured Cu-SiO2 coatings prepared by chemical vapour deposition against hospital related pathogens.Endocannabinoids and the heart.The emerging role of the endocannabinoid system in cardiovascular disease.Do statins have a role in reduction/prevention of post-PCI restenosis?Cannabinoids and atherosclerotic coronary heart disease.
P2860
Q21285148-D88793D2-D7B3-4F9F-B273-B665321B703BQ24631675-32B29896-6AF8-4E90-9C98-940A820DD7F9Q24633122-230D6457-C983-4211-9EBA-45D107A66FA9Q26862515-AB3D3C08-CDEE-485D-97A2-F66A0C718FCDQ27025612-6C62A037-E693-4ECF-9CDB-6F595A1C456CQ27026491-9F6CF0D9-E08A-45EC-8269-1A4A96575ABAQ28569978-D10ABC15-4DA5-4573-B920-37A57624690FQ30470076-DCFCAA49-342D-40A4-BC49-ED769817156EQ33581824-55CC28E1-4895-4734-B48B-233BCF50FED4Q33688381-7E6FDF9F-8338-49B9-92C3-431EE95308D2Q34069579-FE57BF29-1EE6-4E5A-BFCE-2229250EF574Q34098271-5DCBD262-15C0-4D9A-BC7C-2B26E53D4033Q34238768-A60AC8F7-A104-4FEF-BD74-79A364484DD8Q34320270-4EBD8549-C836-448E-8A31-8EDA6BE9B4E2Q34410604-94079647-305C-458C-BEC2-7A8F44AF5403Q34992040-AF981FF8-D7FE-41A4-8685-8BE7FAC00CC5Q35179985-16FE0A71-5015-446A-BBD3-D9C51664CDF2Q35230062-CAF7C8B5-6EBB-4E8A-8AEA-09614B375750Q35951992-B327371B-63E0-4AA0-A08A-9CBA3ABA3DD8Q35966006-0D5CDD1E-57E9-483C-8ED4-EBCAAB74371FQ36089227-5BE0CEFB-5EBD-4388-B2D3-F4EB4E81D137Q36346915-E01602B4-B3CE-46A8-B557-3D37371DA799Q36496316-B01E0651-A56D-4361-B7C4-55FFCDA666EAQ36647969-E0FF051B-9CC9-45E3-A283-34583663A8DBQ36754820-42F005E6-76CB-4693-83D9-8BA5397DB201Q36933683-BDAD1A67-662A-4978-9C49-DAE01127B53CQ36940347-8FF892E8-EC51-4FA3-8DB3-223C2C1FC519Q36993752-E2260AE5-31F9-4004-BA45-7744F775FE43Q37067454-429D42D6-2BE2-45F4-A856-7EA4DE50A4F7Q37105857-C8FCA37B-B197-40F7-9A0E-E8C10563AA04Q37120339-4094AC90-005D-47D6-B3DD-86B3163E859CQ37143578-F8181FC9-B0A3-47CB-8127-49703CEC59A0Q37160279-D08E553D-8710-4A71-B935-BD4E67B96C3EQ37174735-22F78293-E92B-466A-B985-EB33562B5D15Q37330515-86C40E1C-B571-47AB-B616-B347C4251AD1Q37356154-6650938C-B5EE-4536-87D5-DA2AC26B1129Q37412217-27D0BEF5-C79C-492D-9FA4-505CCFEF8F14Q37439386-F92A3294-1E52-4D40-8A02-45B3D2745BE2Q37941867-D18D3CA0-0BEA-4FC3-803E-1D90276D7822Q37978806-2CB76ED6-110B-4DE1-9DF8-0E07E7790D09
P2860
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@ast
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@en
type
label
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@ast
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@en
prefLabel
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@ast
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@en
P2093
P2860
P50
P921
P356
P1476
CB2 cannabinoid receptor agoni ...... l proliferation and migration.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707569
P407
P577
2007-11-12T00:00:00Z